Principal Financial Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$162 Billion
Q1 2024

A detailed history of Principal Financial Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 168,412 shares of REGN stock, worth $177 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

168,412

Previous 130,727 28.83%

Holding current value

$177 Million

Previous $115 Million 41.18%

% of portfolio

0.1%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$902.69 - $993.35 $34 Million - $37.4 Million	37,685 Added 28.83%	168,412 $162 Million
Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $486,813 - $553,707	-628 Reduced 0.48%	130,727 $115 Million
Q3 2023 Nov 02, 2023	SELL	$692.45 - $844.37 $1.16 Million - $1.41 Million	-1,672 Reduced 1.26%	131,355 $108 Million
Q2 2023 Aug 07, 2023	SELL	$700.03 - $830.35 $2.27 Million - $2.69 Million	-3,241 Reduced 2.38%	133,027 $95.6 Million
Q1 2023 May 09, 2023	BUY	$680.49 - $826.97 $1.1 Million - $1.33 Million	1,614 Added 1.2%	136,268 $112 Million

Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $6.9 Million - $7.49 Million	-9,777 Reduced 6.77%	134,654 $97.2 Million
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $8.59 Million - $10.8 Million	14,963 Added 11.56%	144,431 $99.5 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $1.82 Million - $2.46 Million	3,323 Added 2.63%	129,468 $76.5 Million
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $157,111 - $184,385	264 Added 0.21%	126,145 $88.1 Million
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $1.31 Million - $1.62 Million	-2,415 Reduced 1.88%	125,881 $79.5 Million
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $1.54 Million - $1.83 Million	2,682 Added 2.14%	128,296 $77.6 Million
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $2.98 Million - $3.52 Million	-6,296 Reduced 4.77%	125,614 $70.2 Million
Q1 2021 May 10, 2021	SELL	$446.73 - $548.2 $4.45 Million - $5.47 Million	-9,970 Reduced 7.03%	131,910 $62.4 Million
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $3 Million - $3.82 Million	-6,275 Reduced 4.24%	141,880 $68.5 Million
Q3 2020 Nov 06, 2020	SELL	$544.75 - $658.21 $1.97 Million - $2.38 Million	-3,617 Reduced 2.38%	148,155 $82.9 Million
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $16.8 Million - $22 Million	34,093 Added 28.97%	151,772 $94.7 Million
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $2.23 Million - $3.29 Million	6,645 Added 5.98%	117,679 $57.5 Million
Q4 2019 Feb 05, 2020	SELL	$274.13 - $376.51 $946,570 - $1.3 Million	-3,453 Reduced 3.02%	111,034 $41.7 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $448,200 - $521,841	1,639 Added 1.45%	114,487 $31.8 Million
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $884,419 - $1.22 Million	-2,952 Reduced 2.55%	112,848 $35.3 Million
Q1 2019 May 10, 2019	BUY	$372.08 - $439.57 $264,920 - $312,973	712 Added 0.62%	115,800 $47.5 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $518,170 - $621,890	-1,543 Reduced 1.32%	115,088 $43 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $812,889 - $945,700	2,315 Added 2.03%	116,631 $47.1 Million
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $125,793 - $152,485	442 Added 0.39%	114,316 $0
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $93,166 - $116,165	-295 Reduced 0.26%	113,874 $39.2 Million
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $748,460 - $980,785	2,087 Added 1.86%	114,169 $42.9 Million
Q3 2017 Nov 02, 2017	BUY	$431.38 - $504.0 $48.3 Million - $56.5 Million	112,082	112,082 $50.1 Million

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Regeneron Pharmaceuticals, Inc. Transaction History